NCT03864055

Brief Summary

The aim of this study is to report the clinical presentation, Microbiological, laboratory and imaging evaluation, prothrombotic factors analysis, medical and surgical management and outcomes in children with Otogenic Cerebral Sinus Vein Thrombosis (CSVT).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 2, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 3, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 3, 2019

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

February 23, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 6, 2019

Completed
Last Updated

March 6, 2019

Status Verified

March 1, 2019

Enrollment Period

2 months

First QC Date

February 23, 2019

Last Update Submit

March 2, 2019

Conditions

Keywords

otitis mediamastoiditisLateral Sinus Thrombosissubperiosteal abscesssigmoid sinusmastoidmastoidectomyventilation tube

Outcome Measures

Primary Outcomes (5)

  • Clinical Presentation

    Clinical presentation signs and symptoms will be collected and a summary will be represented in a table including all subjects

    All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

  • Cultures result

    the results of cultures from blood, ear secretions, surgery samples, and PCR(polymerize chain reaction assay) will be summarized for the percentage of each pathogen and number of positive results from each type of test

    All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

  • Morbidity and Mortality

    The percentage of Morbidity and Mortality until the end of the follow-up period. Morbidity will include any long term sequelae including permanent neurological deficits, chronic ear inflammation, recurrent mastoiditis, and recurrent thromboembolic events.

    All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

  • Surgical intervention

    Summary of all surgical interventions, and determination of the common types of surgery performed.

    All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

  • Thrombophilia evaluation tests

    Thrombophilia evaluation test results will be collected and a summary will be represented in a table including all subjects

    All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

Secondary Outcomes (1)

  • Imaging Studies results

    All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

Study Arms (1)

Pediatric Otogenic CSVT

Children with Otogenic Cerebral Sinus Vein Thrombosis (CSVT)

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children with otogenic CSVT

You may qualify if:

  • age of 18 years or younger
  • both sexes are included
  • a clinical or radiological finding of mastoiditis in the patient's file
  • Documentation of CSVT in an imaging study, either CT or MRI.

You may not qualify if:

  • age above 18 years
  • lack of a clinical or radiological finding of mastoiditis in the patient's file
  • Lack of documentation of CSVT in an imaging study, either CT or MRI.
  • previous unprovoked venous thromboembolism event.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HaEmek Medical Center

Afula, 1834111, Israel

Location

Related Publications (11)

  • Ichord R. Cerebral Sinovenous Thrombosis. Front Pediatr. 2017 Jul 27;5:163. doi: 10.3389/fped.2017.00163. eCollection 2017.

    PMID: 28798906BACKGROUND
  • Skinner R, Koller K, McIntosh N, McCarthy A, Pizer B; United Kingdom Children's Cancer Study Group (UKCCSG); Paediatric Oncology Nursing Forum (PONF) Supportive Care Group. Prevention and management of central venous catheter occlusion and thrombosis in children with cancer. Pediatr Blood Cancer. 2008 Apr;50(4):826-30. doi: 10.1002/pbc.21332.

    PMID: 17729250BACKGROUND
  • Schneider S, Kapelushnik J, Kraus M, El Saied S, Levi I, Kaplan DM. The association between otogenic lateral sinus thrombosis and thrombophilia - A long-term follow-up. Am J Otolaryngol. 2018 May-Jun;39(3):299-302. doi: 10.1016/j.amjoto.2018.03.013. Epub 2018 Mar 7.

    PMID: 29530427BACKGROUND
  • Kenet G, Waldman D, Lubetsky A, Kornbrut N, Khalil A, Koren A, Wolach B, Fattal A, Kapelushnik J, Tamary H, Yacobovitch J, Raveh E, Revel-Vilk S, Toren A, Brenner B. Paediatric cerebral sinus vein thrombosis. A multi-center, case-controlled study. Thromb Haemost. 2004 Oct;92(4):713-8. doi: 10.1160/TH04-03-0182.

    PMID: 15467900BACKGROUND
  • Zanoletti E, Cazzador D, Faccioli C, Sari M, Bovo R, Martini A. Intracranial venous sinus thrombosis as a complication of otitis media in children: Critical review of diagnosis and management. Int J Pediatr Otorhinolaryngol. 2015 Dec;79(12):2398-403. doi: 10.1016/j.ijporl.2015.10.059. Epub 2015 Nov 5.

    PMID: 26590005BACKGROUND
  • Novoa E, Podvinec M, Angst R, Gurtler N. Paediatric otogenic lateral sinus thrombosis: therapeutic management, outcome and thrombophilic evaluation. Int J Pediatr Otorhinolaryngol. 2013 Jun;77(6):996-1001. doi: 10.1016/j.ijporl.2013.03.030. Epub 2013 Apr 29.

    PMID: 23639339BACKGROUND
  • Kenet G, Kirkham F, Niederstadt T, Heinecke A, Saunders D, Stoll M, Brenner B, Bidlingmaier C, Heller C, Knofler R, Schobess R, Zieger B, Sebire G, Nowak-Gottl U; European Thromboses Study Group. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol. 2007 Jul;6(7):595-603. doi: 10.1016/S1474-4422(07)70131-X.

    PMID: 17560171BACKGROUND
  • Kvaerner KJ, Bentdal Y, Karevold G. Acute mastoiditis in Norway: no evidence for an increase. Int J Pediatr Otorhinolaryngol. 2007 Oct;71(10):1579-83. doi: 10.1016/j.ijporl.2007.06.022. Epub 2007 Aug 20.

    PMID: 17707917BACKGROUND
  • deVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, Camfield CS, David M, Humphreys P, Langevin P, MacDonald EA, Gillett J, Meaney B, Shevell M, Sinclair DB, Yager J; Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001 Aug 9;345(6):417-23. doi: 10.1056/NEJM200108093450604.

    PMID: 11496852BACKGROUND
  • Pang LH, Barakate MS, Havas TE. Mastoiditis in a paediatric population: a review of 11 years experience in management. Int J Pediatr Otorhinolaryngol. 2009 Nov;73(11):1520-4. doi: 10.1016/j.ijporl.2009.07.003. Epub 2009 Sep 15.

    PMID: 19758711BACKGROUND
  • Palma S, Fiumana E, Borgonzoni M, Bovo R, Rosignoli M, Martini A. Acute mastoiditis in children: the "Ferrara" experience. Int J Pediatr Otorhinolaryngol. 2007 Nov;71(11):1663-9. doi: 10.1016/j.ijporl.2007.06.018. Epub 2007 Aug 2.

    PMID: 17681615BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

cultures from blood, ear secretions and samples collected during a surgical procedure. also PCR (polymerase chain reaction assay) analysis for bacterial RNA.

MeSH Terms

Conditions

Lateral Sinus ThrombosisMastoiditisOtitis Media

Condition Hierarchy (Ancestors)

Sinus Thrombosis, IntracranialIntracranial ThrombosisIntracranial Embolism and ThrombosisCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesThromboembolismEmbolism and ThrombosisOsteomyelitisBone Diseases, InfectiousInfectionsBone DiseasesMusculoskeletal DiseasesOtitisEar DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Kfir Siag, MD

    haemek medical center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Siag Kfir

Study Record Dates

First Submitted

February 23, 2019

First Posted

March 6, 2019

Study Start

December 2, 2018

Primary Completion

February 3, 2019

Study Completion

February 3, 2019

Last Updated

March 6, 2019

Record last verified: 2019-03

Locations